Ajooni Biotech Past Earnings Performance
Past criteria checks 4/6
Ajooni Biotech has been growing earnings at an average annual rate of 38.2%, while the Food industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 17.9% per year. Ajooni Biotech's return on equity is 3.1%, and it has net margins of 2.9%.
Key information
38.2%
Earnings growth rate
32.7%
EPS growth rate
| Food Industry Growth | 17.6% |
| Revenue growth rate | 17.9% |
| Return on equity | 3.1% |
| Net Margin | 2.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital
Oct 11
Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Sep 04Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up
Jul 12Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower
Mar 20We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Nov 10We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Jul 13If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late
Feb 16Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 14
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?
Dec 24Revenue & Expenses Breakdown
How Ajooni Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 912 | 26 | 67 | 0 |
| 30 Jun 24 | 848 | 22 | 18 | 0 |
| 31 Mar 24 | 803 | 22 | 64 | 0 |
| 31 Dec 23 | 1,018 | 18 | 53 | 0 |
| 30 Sep 23 | 924 | 15 | 52 | 0 |
| 30 Jun 23 | 832 | 12 | 18 | 0 |
| 31 Mar 23 | 745 | 11 | 51 | 0 |
| 31 Dec 22 | 537 | 5 | 59 | 0 |
| 30 Sep 22 | 624 | 9 | 58 | 0 |
| 30 Jun 22 | 705 | 11 | 16 | 0 |
| 31 Mar 22 | 740 | 10 | 56 | 0 |
| 31 Dec 21 | 697 | 11 | 55 | 0 |
| 30 Sep 21 | 633 | 7 | 54 | 0 |
| 30 Jun 21 | 571 | 4 | 12 | 0 |
| 31 Mar 21 | 510 | 4 | 52 | 0 |
| 31 Dec 20 | 466 | 4 | 22 | 0 |
| 30 Sep 20 | 455 | 7 | 32 | 0 |
| 30 Jun 20 | 416 | 5 | 32 | 0 |
| 31 Mar 20 | 400 | 3 | 32 | 0 |
| 31 Dec 19 | 390 | 4 | 27 | 0 |
| 30 Sep 19 | 379 | 4 | 12 | 0 |
| 30 Jun 19 | 388 | 4 | 12 | 0 |
| 31 Mar 19 | 397 | 4 | 20 | 0 |
| 31 Mar 18 | 424 | 4 | 12 | 0 |
| 31 Mar 17 | 285 | 3 | 6 | 0 |
| 31 Mar 16 | 132 | 1 | 20 | 0 |
| 31 Mar 15 | 72 | 1 | 12 | 0 |
| 31 Mar 14 | 6 | 0 | 1 | 0 |
Quality Earnings: AJOONI has a high level of non-cash earnings.
Growing Profit Margin: AJOONI's current net profit margins (2.9%) are higher than last year (1.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AJOONI's earnings have grown significantly by 38.2% per year over the past 5 years.
Accelerating Growth: AJOONI's earnings growth over the past year (81.2%) exceeds its 5-year average (38.2% per year).
Earnings vs Industry: AJOONI earnings growth over the past year (81.2%) exceeded the Food industry 16.8%.
Return on Equity
High ROE: AJOONI's Return on Equity (3.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 00:46 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ajooni Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|